Cargando…

Editorial: Collagen IV nephropathies: Alport syndrome and beyond

Detalles Bibliográficos
Autores principales:	Borza, Dorin-Bogdan, Abrahamson, Dale R., Gross, Oliver, Savige, Judy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562859/ https://www.ncbi.nlm.nih.gov/pubmed/36250080 http://dx.doi.org/10.3389/fmed.2022.1039949

Ejemplares similares

Pathogenicity of missense variants affecting the collagen IV α5 carboxy non-collagenous domain in X-linked Alport syndrome
por: Gibson, Joel T., et al.
Publicado: (2022)

Alport Syndrome With Kidney Cysts Is Still Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2021)

A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome
por: Odiatis, Christoforos, et al.
Publicado: (2020)

Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice
por: Deltas, Constantinos, et al.
Publicado: (2023)

Genotype-Phenotype Correlations for Pathogenic COL4A3–COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2022)

The Chemical Chaperone, PBA, Reduces ER Stress and Autophagy and Increases Collagen IV α5 Expression in Cultured Fibroblasts From Men With X-Linked Alport Syndrome and Missense Mutations
por: Wang, Dongmao, et al.
Publicado: (2017)

Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?
por: Savige, Judy
Publicado: (2018)

Novel Therapies for Alport Syndrome
por: Chavez, Efren, et al.
Publicado: (2022)

The 2014 International Workshop on Alport Syndrome
por: Miner, Jeffrey H, et al.
Publicado: (2014)

Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy
por: Borza, Dorin-Bogdan
Publicado: (2016)

The importance of clinician, patient and researcher collaborations in Alport syndrome
por: Rheault, Michelle N., et al.
Publicado: (2019)

The 2019 and 2021 International Workshops on Alport Syndrome
por: Daga, Sergio, et al.
Publicado: (2022)

Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular Abnormalities
por: Savige, Judy
Publicado: (2022)

The multifaceted phenotypic and genotypic spectrum of type-IV-collagen-related nephropathy—A human genetics department experience
por: Ćomić, Jasmina, et al.
Publicado: (2022)

Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome
por: Cerkauskaite, Agne, et al.
Publicado: (2022)

A Systematic Review of Pathogenic COL4A5 Variants and Proteinuria in Women and Girls With X-linked Alport Syndrome
por: Gibson, Joel T., et al.
Publicado: (2022)

Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome
Publicado: (1996)

Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining
por: Sato, Masayo, et al.
Publicado: (2021)

CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion
por: Kuwazuru, Jun, et al.
Publicado: (2023)

Non-collagen genes role in digenic Alport syndrome
por: Daga, S., et al.
Publicado: (2019)

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
por: Kashtan, Clifford E., et al.
Publicado: (2012)

iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome
por: Hirayama, Ryuichiro, et al.
Publicado: (2023)

A founder COL4A4 pathogenic variant resulting in autosomal recessive Alport syndrome accounts for most genetic kidney failure in Romani people
por: Plevova, Pavlina, et al.
Publicado: (2023)

Renal X-inactivation in female individuals with X-linked Alport syndrome primarily determined by age
por: Günthner, Roman, et al.
Publicado: (2022)

Collagen IV(α345) dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture’s and Alport diseases
por: Pokidysheva, Elena N., et al.
Publicado: (2021)

Characterization of Sensorineural Hearing Loss in Children with Alport Syndrome
por: Boeckhaus, Jan, et al.
Publicado: (2020)

Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome
por: Gross, Oliver, et al.
Publicado: (2017)

Look Beyond the Cataract: A Case Report on Alport Syndrome
por: Oyediji, Funmilayo Jane, et al.
Publicado: (2022)

X-Linked Alport Syndrome in Women: Genotype and Clinical Course in 24 Cases
por: Mastrangelo, Antonio, et al.
Publicado: (2020)

Alport Syndrome and Oral Mucous Membrane Pemphigoid: An Interesting Case
por: Zisis, Vasileios, et al.
Publicado: (2023)

Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report
por: Bhattacharyya, Aniruddha, et al.
Publicado: (2021)

High-flow arteriovenous fistula in X-linked Alport syndrome: a case report
por: Takahashi, Daisuke, et al.
Publicado: (2023)

Higher Incidence of BK Virus Nephropathy in Pediatric Kidney Allograft Recipients with Alport Syndrome
por: Cho, Young Hoon, et al.
Publicado: (2019)

Women and Alport syndrome
por: Rheault, Michelle N.
Publicado: (2011)

Alport's Syndrome in Pregnancy
por: Mehta, Suchita, et al.
Publicado: (2013)

The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome
por: Yamamura, Tomohiko, et al.
Publicado: (2022)

What patients want to know about genetic testing for kidney disease
por: Savige, Judy, et al.
Publicado: (2023)

Clinical trial recommendations for potential Alport syndrome therapies
por: Weinstock, B. André, et al.
Publicado: (2020)

Pathological features of proteinuric nephropathy resembling Alport syndrome in a young Pyrenean Mountain dog
por: SUGAHARA, Go, et al.
Publicado: (2015)

IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report
por: Hao, Wen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ddcv5lln72scen7a9oglufhqn4